CRAIG R. SMITH, M.D.

Corporate Board Profile

← Back to All Directors

ADAMS DIVERSIFIED EQUITY FUND, INC.

Filing Date Source Excerpt
2007-02-16 Craig R. Smith, M.D., 60, President, Williston Consulting LLC (consultants to the pharmaceutical and biotechnology industries).
2008-02-19 Craig R. Smith, M.D., 61, President, Williston Consulting LLC (consultants to the pharmaceutical and biotechnology industries).
2009-02-17 Craig R. Smith, M.D., 62, President, Williston Consulting LLC (consultants to the pharmaceutical and biotechnology industries).
2010-02-18 Craig R. Smith, M.D., 63, President, Williston Consulting LLC (consultants to the pharmaceutical and biotechnology industries).
2011-02-18 Craig R. Smith, M.D., 64, President, Williston Consulting LLC.
2012-02-21 Dr. Smith brings to the Board extensive experience in the pharmaceuticals and biotech industries.
2013-02-26 Dr. Smith brings to the Board extensive experience in the pharmaceuticals and biotech industries.
2014-02-21 Dr. Smith brings to the Board extensive experience in the pharmaceuticals and biotech industries.
2015-03-10 Dr. Smith brings to the Board extensive experience in the pharmaceuticals and biotech industries.
2016-02-23 Dr. Smith brings to the Board extensive experience in the pharmaceuticals and biotech industries.
2017-02-24 Dr. Smith brings to the Board extensive experience in the pharmaceuticals and biotech industries.
2018-02-26 Dr. Smith, a physician and former long-time member of the faculty at the Johns Hopkins University School of Medicine, brings to the Board extensive experience in the pharmaceuticals and biotech industries.
2019-02-27 Dr. Smith brings to the Board extensive experience in the pharmaceuticals and biotech industries.
2020-02-24 Dr. Smith brings to the Board extensive experience in the pharmaceuticals and biotech industries.

Data sourced from SEC filings. Last updated: 2025-04-15